Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 4 1

Status

Not yet recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 5Uterine Neoplasms 2Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Neoplasms, Unknown Primary 2Lung Neoplasms 2Carcinoma 2Urologic Neoplasms 1Urogenital Neoplasms 1Unresectable Stage III NSCLC 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Pathologic Complete Response 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Male Urogenital Diseases 1Genital Neoplasms, Female 1Genital Diseases, Female 1First-line Advanced NSCLC Patients 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Endocrine System Diseases 1Carcinoma, Ovarian Epithelial 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × CP protocol × Clear all
NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT07102940 2026-02-20

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

George Washington University

Phase 2 Not yet recruiting
50 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT07107217 2025-08-17

Camella

Blokhin's Russian Cancer Research Center

Phase 2 Not yet recruiting
40 enrolled
Breast

Breast Neoplasms

NCT00919880 2014-08-15

Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer

Peking University

Phase 2 Completed
148 enrolled
Breast

Breast Neoplasms

NCT01203267 2010-09-16

Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer

Shanghai Jiao Tong University School of Medicine

Phase 2 Completed
108 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡